A PHASE II RANDOMIZED STUDY OF NovoTTF THERAPY VERSUS SUPPORTIVE CARE IN NON-SMALL CELL LUNG CANCER PATIENTS WITH 1-5 BRAIN METASTASES FOLLOWING OPTIMAL STANDARD LOCAL TREATMENT

被引：0
|
作者：
Weinberg, Uri [1 ]
Kirson, Eilon [2 ]
Farber, Ori [2 ]
Palti, Yoram [1 ]
机构：
[1] Novocure GmbH, Luzern, Switzerland
[2] Novocure Ltd, Haifa, Israel
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
10.1093/neuonc/nou265.35
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NT-37
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Phase 2 Randomized Study of TTFields Versus Supportive Care in Non-Small Cell Lung Cancer Patients With 1 to 5 Brain Metastases Following Optimal Standard Local Treatment
    Weinberg, U.
    Kirson, E.
    Farber, O.
    Palti, Y.
    15TH EUROPEAN CONGRESS OF NEUROSURGERY, 2015, : 343 - 347
  • [2] A PHASE II RANDOMIZED STUDY OF TTFIELDS THERAPY VERSUS SUPPORTIVE CARE IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH 1-3 BRAIN METASTASES (BM) FOLLOWING STEREOTACTIC RADIO-SURGERY (SRS)
    Weinberg, Uri
    Farber, Ori
    Palti, Yoram
    NEURO-ONCOLOGY, 2013, 15 : 84 - 84
  • [3] Should optimal supportive care alone be the standard of care for brain metastases patients from non-small cell lung cancer, who are not eligible for radiosurgery or surgery?
    Tsao, May N.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1320 - S1322
  • [4] Phase II Study of Sunitinib in Patients with Non-small Cell Lung Cancer and Irradiated Brain Metastases
    Novello, Silvia
    Camps, Carlos
    Grossi, Francesco
    Mazieres, Julien
    Abrey, Lauren
    Vernejoux, Jean-Marc
    Thall, Aron
    Patyna, Shem
    Usari, Tiziana
    Wang, Zhixiao
    Chao, Richard C.
    Scagliotti, Giorgio
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) : 1260 - 1266
  • [5] A phase II study of sunitinib in patients with non-small cell lung cancer and irradiated brain metastases
    Novello, Silvia
    Abrey, Lauren
    Grossi, Francesco
    Camps, Carlos
    Mazieres, Julien
    Fain, Jerry
    Vernejoux, Jean-Marc
    Carpeno, Javier de Castro
    Selaru, Paulina
    Patyna, Shem
    Torigoe, Yasuhiro
    Chao, Richard
    Scagliotti, Giorgio
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S356 - S356
  • [6] Standard maintenance therapy versus local consolidative radiation therapy and standard maintenance therapy in 1-5 sites of oligometastatic non-small cell lung cancer: a study protocol of phase III randomised controlled trial
    Tibdewal, Anil
    Agarwal, Jai Prakash
    Srinivasan, Shashank
    Mummudi, Naveen
    Noronha, Vanita
    Prabhash, Kumar
    Patil, Vijay
    Purandare, Nilendu
    Janu, Amit
    Kannan, Sadhna
    BMJ OPEN, 2021, 11 (03):
  • [7] Treatment options for brain metastases in patients with non-small cell lung cancer
    Sadaf Taimur
    Martin J. Edelman
    Current Treatment Options in Oncology, 2003, 4 (1) : 89 - 95
  • [8] Phase II Study of Erlotinib with Concurrent Whole-brain Radiation Therapy for Patients with Brain Metastases from Non-small Cell Lung Cancer
    Welsh, J. W.
    Kim, E.
    Amini, A.
    Allen, P.
    Chang, J.
    Komaki, R.
    Nguyen, N.
    Holt, J.
    Erdman, D.
    Stea, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S136 - S136
  • [9] PHASE II STUDY OF ERLOTINIB WITH CONCURRENT WHOLE-BRAIN RADIATION THERAPY FOR PATIENTS WITH BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
    Welsh, James
    Amini, Arya
    Kim, Edward
    Allen, Pamela K.
    Chang, Joe Y.
    Garland, Linda
    Komaki, Ritsuko
    Stea, Baldassarre
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1587 - S1587
  • [10] Optimal Timing And Technique Of Local Therapy For Brain Metastases From Non-Small Cell Lung Cancer With Driver Mutations
    El Shafie, R.
    Eichkorn, T.
    Weber, D.
    Bozorgmehr, F.
    Koenig, L.
    Rieken, S.
    Thomas, M.
    Debus, J.
    Christopoulos, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E718 - E718
12345